IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,036 | -99.9% | 400,000 | 0.0% | 0.15% | -1.3% |
| Q3 2022 | $3,964,000 | +1.0% | 400,000 | 0.0% | 0.15% | +2.7% |
| Q2 2022 | $3,924,000 | 0.0% | 400,000 | 0.0% | 0.15% | +8.1% |
| Q1 2022 | $3,924,000 | +1.1% | 400,000 | 0.0% | 0.14% | -1.5% |
| Q4 2021 | $3,880,000 | +0.1% | 400,000 | 0.0% | 0.14% | -2.1% |
| Q3 2021 | $3,876,000 | +0.2% | 400,000 | 0.0% | 0.14% | +6.9% |
| Q2 2021 | $3,868,000 | – | 400,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ampfield Management, L.P. | 44,543 | $431,000 | 0.35% |
| MANGROVE PARTNERS IM, LLC | 200,000 | $1,934,000 | 0.20% |
| SPRING CREEK CAPITAL LLC | 400,000 | $3,868,000 | 0.19% |
| Vestcor Inc | 400,000 | $3,868,000 | 0.13% |
| KNOTT DAVID M | 36,000 | $348,000 | 0.12% |
| Radcliffe Capital Management, L.P. | 300,000 | $2,901,000 | 0.09% |
| Hudson Bay Capital Management LP | 621,750 | $6,012,000 | 0.07% |
| BERKLEY W R CORP | 68,776 | $666,000 | 0.07% |
| PICTON MAHONEY ASSET MANAGEMENT | 200,000 | $1,934,000 | 0.06% |
| Polar Asset Management Partners Inc. | 500,000 | $4,835,000 | 0.05% |